A high-profile 2013 demonstration of a lab-grown beef burger - made from cattle muscle stem cells cultured in fetal bovine serum and funded by Sergey Brin at a cost of $330,000 - launched a global boom in cultivated-meat startups. Promises ranged from steep reductions in greenhouse gases and antibiotic use to eliminating zoonotic risks, and investors poured roughly $3 billion into about 140 companies. Reality undercut the hype: products lacked fat and flavor, production proved staggeringly expensive and energy‑intensive, scaling required new manufacturing and skilled labor, regulators imposed prolonged inspections, and odd setbacks like rodent DNA contamination made headlines. Investment collapsed after 2021 (industry funding fell to $177 million in 2023), several U.S. states passed bans on cultivated-meat sales or production, and commercial availability today is essentially limited to one shop in Singapore.
The narrative follows a reporter who, long a vegetarian and eager to taste cell-grown meat, tracks a tentative comeback centered in North Carolina: Jeff Bezos donated $30 million to establish a sustainable‑protein center at NC State, and Israeli firm Believer Meats broke ground on a 200,000‑square‑foot plant claiming a 21‑million‑pound annual capacity and earning an FDA “No Questions” letter. The account argues that techno-optimism and venture capital propelled extravagant expectations that largely went unmet, even as renewed funding and facilities keep alive the possibility that cultivated meat could yet move from spectacle to scalable product.
Summary generated by AI from the linked article. hn.today is not affiliated with Hacker News or Y Combinator.